1-16924429-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014675.5(CROCC):c.301C>T(p.Arg101Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,613,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 52)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
CROCC
NM_014675.5 missense
NM_014675.5 missense
Scores
2
4
10
Clinical Significance
Conservation
PhyloP100: 2.54
Genes affected
CROCC (HGNC:21299): (ciliary rootlet coiled-coil, rootletin) Predicted to enable kinesin binding activity and structural molecule activity. Involved in several processes, including centriole-centriole cohesion; positive regulation of cilium assembly; and positive regulation of protein localization to cilium. Located in cytoskeleton; cytosol; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.059315562).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CROCC | NM_014675.5 | c.301C>T | p.Arg101Cys | missense_variant | 3/37 | ENST00000375541.10 | NP_055490.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CROCC | ENST00000375541.10 | c.301C>T | p.Arg101Cys | missense_variant | 3/37 | 5 | NM_014675.5 | ENSP00000364691.4 | ||
CROCC | ENST00000445545.6 | c.148C>T | p.Arg50Cys | missense_variant | 2/24 | 5 | ENSP00000402626.2 | |||
CROCC | ENST00000467938.5 | c.30+1631C>T | intron_variant | 2 | ENSP00000480016.1 | |||||
CROCC | ENST00000466256.6 | n.126-5857C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152274Hom.: 0 Cov.: 52
GnomAD3 genomes
AF:
AC:
62
AN:
152274
Hom.:
Cov.:
52
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000153 AC: 38AN: 248876Hom.: 0 AF XY: 0.000141 AC XY: 19AN XY: 135088
GnomAD3 exomes
AF:
AC:
38
AN:
248876
Hom.:
AF XY:
AC XY:
19
AN XY:
135088
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000133 AC: 195AN: 1460844Hom.: 0 Cov.: 37 AF XY: 0.000147 AC XY: 107AN XY: 726740
GnomAD4 exome
AF:
AC:
195
AN:
1460844
Hom.:
Cov.:
37
AF XY:
AC XY:
107
AN XY:
726740
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152392Hom.: 0 Cov.: 52 AF XY: 0.000389 AC XY: 29AN XY: 74522
GnomAD4 genome
AF:
AC:
62
AN:
152392
Hom.:
Cov.:
52
AF XY:
AC XY:
29
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
8
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
31
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.301C>T (p.R101C) alteration is located in exon 3 (coding exon 3) of the CROCC gene. This alteration results from a C to T substitution at nucleotide position 301, causing the arginine (R) at amino acid position 101 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at